SEC Form 4 · accession 0000899243-18-007375
Adicet Bio, Inc. · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John J McCabe
Officer — Vice President, Finance
Period of report
Mar 13, 2018
Accepted (ET)
Mar 14, 2018 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720580
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.45 | Mar 13, 2018 | A | 4,603 | A | — | Mar 13, 2028 | Common Stock | 4,603 | 4,603 | D |
Explanation of responses
- F1This stock option award was issued pursuant to the resTORbio, Inc. 2018 Stock Option and Incentive Plan. 25% of the shares shall vest on March 13, 2019; and the remaining 75% shall vest in equal quarterly installments thereafter.